Company intelligence / Profile preview

Enosi Life Sciences

San Diego, California, USAenosi-life.com ↗
Ownership
Private
Development stage
Other
01

Overview

All pipeline programs are preclinical. No clinical results have been reported yet. The company has filed patents for its proprietary molecules EN1001, EN2001, and EN3001 targeting autoimmune diseases, cancer, acute inflammation, and fibrotic conditions. These therapeutics are designed to selectively inhibit harmful inflammatory pathways while sparing or enhancing beneficial immune functions.

Therapeutic areas
OncologyRare DiseasesImmunologyNeurologyInfectious Diseases
Modalities
Fusion proteinsMonoclonal antibodiesBiological productsAntibodies
Industry
Biotech
02

Drug pipeline

4 assets

EN2001

Preclinical

3 more assets in the full pipeline.

03

Partnerships

Danuo Science Group – partnership to develop the Growth Factor Trap (“EN‑2000 Program”) and TNFR1 Blocker (“EN‑1000 Program”) for Greater China; Danuo provides $5M upfront licensing fees plus conditional funding. Estimated value over $100M including development milestones.

Beyond the preview

Go deeper on Enosi Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enosi Life Sciences.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call